Publications To Date


    Filter Publications

    PAGE 7 OF 86 | DISPLAYING 91 - 105 OF 1278 RESULTS

    Abdulla M et al., Cell‐of‐origin determined by both gene expression profiling and immunohistochemistry is the strongest predictor of survival in patients with diffuse large B‐cell lymphoma, , Am J Hematol., Nov 07, 2019

    Song F et al., Identification of key microRNAs and hub genes in non‐small‐cell lung cancer using integrative bioinformatics and functional analyses, , J Cell Biochem., Nov 06, 2019

    Mahalingam D et al., Pembrolizumab in combination with the oncolytic virus pelareorep and chemotherapy in patients with advanced pancreatic adenocarcinoma: a Phase 1b study, , Clin Cancer Res, Nov 06, 2019

    Yan W et al., Molecular profiling of radical prostatectomy tissue from patients with no sign of progression identifies ERG as the strongest independent predictor of recurrence., , Oncotarget, Nov 05, 2019

    Taibi A et al., Effects of Flaxseed and Its Components on Mammary Gland MiRNome: Identification of Potential Biomarkers to Prevent Breast Cancer Development, , Nutrients, Nov 04, 2019

    Conteduca V et al., Plasma Androgen Receptor in Prostate Cancer., , Cancers (Basel), Nov 04, 2019

    Damotte D et al., The tumor inflammation signature (TIS) is associated with anti-PD-1 treatment benefit in the CERTIM pan-cancer cohort., , J Transl Med., Nov 04, 2019

    Duval KEA et al., Immunogenetic effects of low dose (CEM43 30) magnetic nanoparticle hyperthermia and radiation in melanoma cells., , Int J Hyperthermia, Nov 01, 2019

    Yu J et al., Genetic Aberrations in the CDK4 Pathway Are Associated with Innate Resistance to PD-1 Blockade in Chinese Patients with Non-Cutaneous Melanoma., , Clin Cancer Res, Nov 01, 2019

    Kahraman DC et al., Targeting PI3K/Akt/mTOR Pathway Identifies Differential Expression and Functional Role of IL8 in Liver Cancer Stem Cell Enrichment, , Mol Cancer Ther, Nov 01, 2019

    Mog B et al., Nano-Antagonist Alleviates Inflammation and Allows for MRI of Atherosclerosis., , Nanotheranostics, Nov 01, 2019

    Yarchoan M et al., MEK inhibition suppresses B regulatory cells and augments anti-tumor immunity., , PLoS One, Oct 31, 2019

    Fattore L et al., Single cell analysis to dissect molecular heterogeneity and disease evolution in metastatic melanoma., , Cell Death Dis, Oct 31, 2019

    Canon J et al., The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity , , Nature, Oct 30, 2019

    Giannini R et al., Immune Profiling of Thyroid Carcinomas Suggests the Existence of Two Major Phenotypes: An ATC-Like and a PDTC-Like., , J Clin Endocrinol Metab, Oct 28, 2019